According to Swedish Orphan Biovitrum's latest financial reports the company's current revenue (TTM ) is ยฃ1.85 Billion. an increase over the revenue in the year 2023 that were of ยฃ1.65 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | ยฃ1.95 B | 18.46% |
2023 | ยฃ1.65 B | 8.31% |
2022 | ยฃ1.52 B | 16.75% |
2021 | ยฃ1.30 B | 5.97% |
2020 | ยฃ1.23 B | 6.83% |
2019 | ยฃ1.15 B | 41.34% |
2018 | ยฃ0.81 B | 42.41% |
2017 | ยฃ0.57 B | 16.28% |
2016 | ยฃ0.49 B | 90.45% |
2015 | ยฃ0.25 B | 9.17% |
2014 | ยฃ0.23 B | 17.14% |
2013 | ยฃ0.20 B | 13.21% |
2012 | ยฃ0.17 B | -4.61% |
2011 | ยฃ0.18 B | 8.04% |
2010 | ยฃ0.17 B | 62.36% |
2009 | ยฃ0.10 B |